Great Valley Advisor Group’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,415
| Closed | -$55.9K | – | 717 |
|
|
2022
Q4 | $55.9K | Sell |
3,415
-1,838
| -35% | -$30.1K | ﹤0.01% | 675 |
|
|
2022
Q3 | $48K | Hold |
5,253
| – | – | ﹤0.01% | 656 |
|
|
2022
Q2 | $26K | Hold |
5,253
| – | – | ﹤0.01% | 659 |
|
|
2022
Q1 | $40K | Sell |
5,253
-400
| -7% | -$3.05K | ﹤0.01% | 579 |
|
|
2021
Q4 | $51K | Sell |
5,653
-1,200
| -18% | -$10.8K | ﹤0.01% | 584 |
|
|
2021
Q3 | $112K | Sell |
6,853
-1,200
| -15% | -$19.6K | 0.01% | 561 |
|
|
2021
Q2 | $254K | Buy |
+8,053
| New | +$254K | 0.02% | 484 |
|